https://www.selleckchem.com/pr....oducts/sp-600125.htm
001). When plasma PCSK9 was 255.05 ng/ml, the risk of developing higher levels of LDL-C significantly increased in PNS patients (OR = 3.83, 95%CI 1.25-11.68, p = 0.018).Conclusions Plasma PCSK9 levels in newly diagnosed PNS patients were markedly increased, and elevated PCSK9 abundance was positively correlated with elevated serum TC and LDL-C levels, suggesting that PCSK9 may emerge as a novel therapeutic target in NS-associated hypercholesterolemia.Background. Endoscopic submucosal dissections (ESDs) allow removal of large gastr
Curtir
Comentario
Compartilhar
